Xavier Barril
Keine laufenden Positionen mehr
Profil
Xavier Barril is the founder of Minoryx Therapeutics SL, which was founded in 2011.
Dr. Barril is also the founder of Oniria Therapeutics SL.
Dr. Barril's former job was as the Chief Scientific Officer at Gain Therapeutics, Inc. from 2018 to 2024.
Dr. Barril obtained a doctorate degree from the University of Barcelona.
Ehemalige bekannte Positionen von Xavier Barril
| Unternehmen | Position | Ende |
|---|---|---|
| GAIN THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01.01.2024 |
Oniria Therapeutics SL
 Oniria Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Oniria Therapeutics SL is a Spanish company that focuses on researching and developing treatments for cancer patients. The company is based in Barcelona, Spain. Oniria Therapeutics was founded by Carlos Galdeano, Héctor G. Palmer, Isabel Puig, Esther Riambau, and Xavier Barril. Esther Riambau has been the CEO since incorporation. | Founder | - |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Founder | - |
Ausbildung von Xavier Barril
| University of Barcelona | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| GAIN THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Minoryx Therapeutics SL
Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Health Technology |
Oniria Therapeutics SL
Oniria Therapeutics SL Miscellaneous Commercial ServicesCommercial Services Oniria Therapeutics SL is a Spanish company that focuses on researching and developing treatments for cancer patients. The company is based in Barcelona, Spain. Oniria Therapeutics was founded by Carlos Galdeano, Héctor G. Palmer, Isabel Puig, Esther Riambau, and Xavier Barril. Esther Riambau has been the CEO since incorporation. | Commercial Services |
